Locoregional data chemotherapy cancer regional perfusion. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Lung Heart Cell Line, Tumor Lymph Nodes Axilla Neoplastic Stem Cells Tumor Cells, Cultured

Organisms2

Dogs Mice, Nude

Diseases62

Neoplasm Recurrence, Local Breast Neoplasms Lung Neoplasms Carcinoma, Squamous Cell Head and Neck Neoplasms Neoplasm Metastasis Neoplasms Ovarian Neoplasms Lymphatic Metastasis Stomach Neoplasms Carcinoma Liver Neoplasms Carcinoma, Non-Small-Cell Lung Nasopharyngeal Neoplasms Adenocarcinoma Neoplasm Invasiveness Colonic Neoplasms Disease Progression Pancreatic Neoplasms Colorectal Neoplasms Esophageal Neoplasms Prostatic Neoplasms Rectal Neoplasms Bone Neoplasms Mouth Neoplasms Peritoneal Neoplasms Oropharyngeal Neoplasms Recurrence Uterine Cervical Neoplasms Testicular Neoplasms Carcinoma, Hepatocellular Urinary Bladder Neoplasms Neoplasms, Second Primary Radiation Injuries Brain Neoplasms Neutropenia Sarcoma Melanoma Nausea Vomiting Hypopharyngeal Neoplasms Lymphoma, Non-Hodgkin Laryngeal Neoplasms Pharyngeal Neoplasms Skin Neoplasms Carcinoma, Lobular Hodgkin Disease Thyroid Neoplasms Genetic Predisposition to Disease Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasm, Residual Radiodermatitis Mucositis Anus Neoplasms Neovascularization, Pathologic Tongue Neoplasms Soft Tissue Neoplasms Endometrial Neoplasms Neoplasms, Squamous Cell Lymphoma Disease Models, Animal

Chemicals and Drugs55

Nitrogen Radioisotopes Cisplatin Antineoplastic Agents Cyclophosphamide Doxorubicin Paclitaxel Carboplatin Methotrexate Taxoids Etoposide Tumor Markers, Biological Radiopharmaceuticals Fluorouracil Deoxycytidine Receptors, Estrogen Antimetabolites, Antineoplastic Receptor, erbB-2 Antineoplastic Agents, Phytogenic Vinblastine Mitomycin Organoplatinum Compounds Antibodies, Monoclonal, Humanized Receptors, Progesterone Tamoxifen Antineoplastic Agents, Alkylating Antibodies, Monoclonal Neoplasm Proteins Anthracyclines Bleomycin Melphalan Cancer Vaccines Antineoplastic Agents, Hormonal Ifosfamide Antibiotics, Antineoplastic Camptothecin Cytarabine Technetium Tc 99m Sestamibi RNA, Messenger Contrast Media Organotechnetium Compounds Yttrium Isotopes Receptor, Epidermal Growth Factor Tumor Suppressor Protein p53 Fluorodeoxyglucose F18 DNA, Neoplasm Picibanil Granulocyte Colony-Stimulating Factor Ki-67 Antigen Radiation-Sensitizing Agents Tegafur Dacarbazine RNA, Small Interfering Mitoxantrone Carmustine Lomustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment103

Chemotherapy, Cancer, Regional Perfusion Perfusion Antineoplastic Combined Chemotherapy Protocols Ventilation-Perfusion Ratio Chemotherapy, Adjuvant Microspheres Tomography, Emission-Computed, Single-Photon Combined Modality Therapy Tomography, Emission-Computed Perfusion Imaging Positron-Emission Tomography Treatment Outcome Neoplasm Staging Feasibility Studies Disease-Free Survival Survival Analysis Prognosis Survival Rate Radiotherapy, Adjuvant Myocardial Perfusion Imaging Neoadjuvant Therapy Radiotherapy Follow-Up Studies Mastectomy Radiotherapy Dosage Drug Administration Schedule Chemoradiotherapy Prospective Studies Early Detection of Cancer Retrospective Studies Mastectomy, Modified Radical Kaplan-Meier Estimate Dose Fractionation Mastectomy, Segmental Induction Chemotherapy Tomography, X-Ray Computed Radiotherapy, Intensity-Modulated Lymph Node Excision Sensitivity and Specificity Clinical Trials as Topic Multivariate Analysis Risk Assessment Predictive Value of Tests Salvage Therapy Tumor Burden Hyperthermia, Induced Risk Factors Treatment Failure Chemoembolization, Therapeutic Palliative Care Reproducibility of Results Immunohistochemistry Infusions, Intravenous Anesthesia, Conduction Randomized Controlled Trials as Topic Infusions, Intra-Arterial Magnetic Resonance Imaging Proportional Hazards Models Reverse Transcriptase Polymerase Chain Reaction Chemoradiotherapy, Adjuvant Risk Neoplasm Transplantation Xenograft Model Antitumor Assays Antineoplastic Protocols Gene Expression Profiling Actuarial Analysis Immunotherapy Neoplasm Grading Preoperative Care Esophagectomy Anesthesia, Local SEER Program Transplantation, Autologous Odds Ratio Analysis of Variance Registries Cohort Studies Drug Screening Assays, Antitumor Patient Selection Mastectomy, Extended Radical Dose-Response Relationship, Radiation Oral Surgical Procedures Drug Delivery Systems Probability Blotting, Western Radiotherapy, Conformal Transplantation, Heterologous Immunoenzyme Techniques Confidence Intervals Biopsy Lymphatic Irradiation Infusions, Parenteral Pilot Projects Mastectomy, Radical Multimodal Imaging Biopsy, Needle Molecular Targeted Therapy Radioimmunotherapy Drug Therapy Postoperative Period Pneumonectomy Sentinel Lymph Node Biopsy Disease Models, Animal

Phenomena and Processes22

Ventilation-Perfusion Ratio Coronary Circulation Pulmonary Circulation Regional Blood Flow Cerebrovascular Circulation Hemodynamics Time Factors Drug Resistance, Neoplasm Sensitivity and Specificity Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Risk Apoptosis Cell Survival Odds Ratio Mutation Genetic Predisposition to Disease Dose-Response Relationship, Radiation Probability Premenopause Cell Proliferation Drug Synergism

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Radiation Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Survival National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science5

Survival Rate Radiotherapy, Intensity-Modulated SEER Program Registries Radiotherapy, Conformal

Named Groups1

Health Care38

Treatment Outcome Feasibility Studies Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Retrospective Studies Kaplan-Meier Estimate Sensitivity and Specificity Clinical Trials as Topic Multivariate Analysis Risk Assessment Predictive Value of Tests Risk Factors Treatment Failure Palliative Care Reproducibility of Results Age Factors Randomized Controlled Trials as Topic Proportional Hazards Models Risk Antineoplastic Protocols Radiation Injuries Actuarial Analysis Preoperative Care SEER Program Odds Ratio Analysis of Variance Registries Cohort Studies Patient Selection Dose-Response Relationship, Radiation National Cancer Institute (U.S.)Probability Confidence Intervals Pilot Projects Postoperative Period

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Chemotherapy, Cancer, Regional Perfusion Perfusion Nitrogen Radioisotopes Antineoplastic Combined Chemotherapy Protocols Ventilation-Perfusion Ratio Chemotherapy, Adjuvant Coronary Circulation Pulmonary Circulation Microspheres Tomography, Emission-Computed, Single-Photon Regional Blood Flow Combined Modality Therapy Tomography, Emission-Computed Neoplasm Recurrence, Local Perfusion Imaging Dogs Breast Neoplasms Positron-Emission Tomography Cisplatin Treatment Outcome Neoplasm Staging Feasibility Studies Disease-Free Survival Cerebrovascular Circulation Antineoplastic Agents Survival Analysis Prognosis Survival Rate Radiotherapy, Adjuvant Lung Neoplasms Hemodynamics Carcinoma, Squamous Cell Head and Neck Neoplasms Cyclophosphamide Myocardial Perfusion Imaging Neoadjuvant Therapy Lung Neoplasm Metastasis Heart Doxorubicin Radiotherapy Follow-Up Studies Mastectomy Radiotherapy Dosage Neoplasms Paclitaxel Drug Administration Schedule Chemoradiotherapy Ovarian Neoplasms Lymphatic Metastasis Stomach Neoplasms Carcinoma Prospective Studies Liver Neoplasms Early Detection of Cancer Retrospective Studies Carcinoma, Non-Small-Cell Lung Mastectomy, Modified Radical Nasopharyngeal Neoplasms Time Factors Kaplan-Meier Estimate Adenocarcinoma Neoplasm Invasiveness Drug Resistance, Neoplasm Carboplatin Dose Fractionation Methotrexate Taxoids Etoposide Tumor Markers, Biological Colonic Neoplasms Disease Progression Pancreatic Neoplasms Radiopharmaceuticals Colorectal Neoplasms Mastectomy, Segmental Fluorouracil Deoxycytidine Induction Chemotherapy Receptors, Estrogen Antimetabolites, Antineoplastic Esophageal Neoplasms Tomography, X-Ray Computed Prostatic Neoplasms Radiotherapy, Intensity-Modulated Lymph Node Excision Cell Line, Tumor Receptor, erbB-2 Sensitivity and Specificity Mice, Nude Antineoplastic Agents, Phytogenic Clinical Trials as Topic Multivariate Analysis Gene Expression Regulation, Neoplastic Rectal Neoplasms Bone Neoplasms Vinblastine Dose-Response Relationship, Drug Risk Assessment Predictive Value of Tests

No FAQ available that match "locoregional data chemotherapy cancer regional perfusion"